User:pritoxaximabchimerichuma022136

A novel monoclonal antibody, Pritoxaximab – formerly known as DXX00601 – shows significant promise in the therapy of acute transfusion-related disease (TRALI). Engineered by Bio-X, Pritoxaximab

https://www.targetmol.com/compound/pritoxaximab